Y200-0453 Screening compound: N-(6-methoxy-1,3-benzothiazol-2-yl)pyrazine-2-carboxamide

Y200-0453 Screening compound: N-(6-methoxy-1,3-benzothiazol-2-yl)pyrazine-2-carboxamide
Y200-0453 Screening compound: N-(6-methoxy-1,3-benzothiazol-2-yl)pyrazine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-0453
N-(6-methoxy-1,3-benzothiazol-2-yl)pyrazine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-0453

Molecular Formula

C13H10N4O2S (C13 H10 N4 O2 S)

Compound Name

N-(6-methoxy-1,3-benzothiazol-2-yl)pyrazine-2-carboxamide

IUPAC name

N-(6-methoxy-13-benzothiazol-2-yl)pyrazine-2-carboxamide

SMILES

COc(cc1)cc2c1nc(NC(c1nccnc1)=O)s2

InChI

InChI=1S/C13H10N4O2S/c1-19-8-2-3-9-11(6-8)20-13(16-9)17-12(18)10-7-14-4-5-15-10/h2-7H,1H3,(H,16,17,18)

InChI Key

IFJFOLOYHFRQBP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02748972

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

286.31

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.233

Distribution Coefficient, logD

2.231

Water Solubility, LogSw

-2.70

Polar Surface Area

59.200

Acid Dissociation Constant (pKa)

9.64

Base Dissociation Constant (pKb)

0.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

7.70

Y200-0453 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Human Receptors Annotated Library (5376 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
  • GPCR
Mechanism of action:
  • Epigenetic
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y200-0453 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-0453?
Check Price and Availability of Y200-0453, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-0453 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-0453
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-0453
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-0453 available by request